105 related articles for article (PubMed ID: 18430493)
1. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
2.
Andrianov AK; Marin A; Wang R; Chowdhury A; Agnihotri P; Yunus AS; Pierce BG; Mariuzza RA; Fuerst TR
Mol Pharm; 2021 Feb; 18(2):726-734. PubMed ID: 32530637
[TBL] [Abstract][Full Text] [Related]
3. Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP.
Valencia SM; Zacharia A; Marin A; Matthews RL; Wu CK; Myers B; Sanders C; Difilippantonio S; Kirnbauer R; Roden RB; Pinto LA; Shoemaker RH; Andrianov AK; Marshall JD
Hum Vaccin Immunother; 2021 Aug; 17(8):2748-2761. PubMed ID: 33573433
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies.
Mapletoft JW; Latimer L; Babiuk LA; van Drunen Littel-van den Hurk S
Clin Vaccine Immunol; 2010 Jan; 17(1):23-35. PubMed ID: 19864487
[TBL] [Abstract][Full Text] [Related]
5. Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels.
Reidel IG; Curti CC; Dorémus L; Béré E; Delwail A; Russi RC; Lecron JC; Morel F; García MI; Müller DM; Jégou JF; Veaute CM
Vaccine; 2024 Mar; 42(8):1953-1965. PubMed ID: 38378388
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.
de Jong S; Chikh G; Sekirov L; Raney S; Semple S; Klimuk S; Yuan N; Hope M; Cullis P; Tam Y
Cancer Immunol Immunother; 2007 Aug; 56(8):1251-64. PubMed ID: 17242927
[TBL] [Abstract][Full Text] [Related]
7. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.
Brazolot Millan CL; Weeratna R; Krieg AM; Siegrist CA; Davis HL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15553-8. PubMed ID: 9861007
[TBL] [Abstract][Full Text] [Related]
8. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.
Andrianov AK; DeCollibus DP; Gillis HA; Kha HH; Marin A; Prausnitz MR; Babiuk LA; Townsend H; Mutwiri G
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18936-41. PubMed ID: 19864632
[TBL] [Abstract][Full Text] [Related]
9. CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.
Saha A; Baral RN; Chatterjee SK; Mohanty K; Pal S; Foon KA; Primus FJ; Krieg AM; Weiner GJ; Bhattacharya-Chatterjee M
Cancer Immunol Immunother; 2006 May; 55(5):515-27. PubMed ID: 16044253
[TBL] [Abstract][Full Text] [Related]
10. A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus.
Wang Y; Liu S; Li B; Sun X; Pan Q; Zheng Y; Liu J; Zhao Y; Wang J; Liu L; Du E
Front Immunol; 2024; 15():1336239. PubMed ID: 38322258
[TBL] [Abstract][Full Text] [Related]
11. The orientation of CpG conjugation on aluminum oxyhydroxide nanoparticles determines the immunostimulatory effects of combination adjuvants.
Liang Z; Bao H; Yao Z; Li M; Chen C; Zhang L; Wang H; Guo Y; Ma Y; Yang X; Yu G; Zhang J; Xue C; Sun B; Mao C
Biomaterials; 2024 Jul; 308():122569. PubMed ID: 38626556
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine.
Yu X; Min H; Yao S; Yao G; Zhang D; Zhang B; Chen M; Liu F; Cui L; Zheng L; Cao Y
Int Immunopharmacol; 2024 Apr; 131():111817. PubMed ID: 38460299
[TBL] [Abstract][Full Text] [Related]
13. Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine.
Marin A; Chowdhury A; Valencia SM; Zacharia A; Kirnbauer R; Roden RBS; Pinto LA; Shoemaker RH; Marshall JD; Andrianov AK
Nanomedicine; 2021 Apr; 33():102359. PubMed ID: 33476764
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.
Klinman DM; Conover J; Coban C
Infect Immun; 1999 Nov; 67(11):5658-63. PubMed ID: 10531213
[TBL] [Abstract][Full Text] [Related]
15. The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.
Eng NF; Bhardwaj N; Mulligan R; Diaz-Mitoma F
Hum Vaccin Immunother; 2013 Aug; 9(8):1661-72. PubMed ID: 23732907
[TBL] [Abstract][Full Text] [Related]
16. Systems Pharmacology-based strategy to screen new adjuvant for hepatitis B vaccine from Traditional Chinese Medicine Ophiocordyceps sinensis.
Wang J; Liu R; Liu B; Yang Y; Xie J; Zhu N
Sci Rep; 2017 Mar; 7():44788. PubMed ID: 28317886
[TBL] [Abstract][Full Text] [Related]
17. Immunopotentiating Polyphosphazene Delivery Systems: Supramolecular Self-Assembly and Stability in the Presence of Plasma Proteins.
Marin A; Kethanapalli SH; Andrianov AK
Mol Pharm; 2024 Feb; 21(2):791-800. PubMed ID: 38206583
[TBL] [Abstract][Full Text] [Related]
18. Modulating Adjuvant Release Kinetics From Scaffold Vaccines to Tune Adaptive Immune Responses.
Sobral MC; Cabizzosu L; Kang SJ; Feng Z; Ijaz H; Mooney DJ
Adv Healthc Mater; 2024 May; ():e2304574. PubMed ID: 38739747
[TBL] [Abstract][Full Text] [Related]
19. Kinome Analysis to Define Mechanisms of Adjuvant Action: PCEP Induces Unique Signaling at the Injection Site and Lymph Nodes.
Awate S; Scruten E; Mutwiri G; Napper S
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746541
[TBL] [Abstract][Full Text] [Related]
20. The Adjuvants Polyphosphazene (PCEP) and a Combination of Curdlan Plus Leptin Promote a Th17-Type Immune Response to an Intramuscular Vaccine in Mice.
Chaffey A; Hamonic G; Chand D; Mutwiri GK; Wilson HL
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34069081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
